News
ACIP Backs RSV Shot for Some 50- to 59-Year-Olds, New Meningitis Vaccine
At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several vaccines but did not vote on the influenza vaccine, as had previously been scheduled.
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
A CDC advisory panel voted to recommend RSV vaccines for at-risk adults 50 to 59, a sought-after expansion by vaccine makers ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted ...
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...
3don MSN
One less infant, under the age of six months, was hospitalised each day following the release of the Respiratory Syncytial ...
After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback